Clinical trial

Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study

NCT02390245

StatusCOMPLETED
Study typeINTERVENTIONAL
Start date2014-09-01
PhaseNA

Study timeline

Study start (actual)2014-09-01Date precision: month
Registry last updated2022-08-22
Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

What this registered study describes

Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study is a interventional study listed under registry identifier NCT02390245. Its last published status is COMPLETED. Registry status does not establish that enrollment is currently open at every study site.

The published record lists 13 condition label(s), 3 intervention label(s), and 7 sponsor/collaborator entry or entries. The structured information below allows these links to be examined individually; intervention registration is not an efficacy claim.

Source: the original ClinicalTrials.gov study record. Always check the protocol, eligibility, dates, results (when posted), and contacts at the original source.

Conditions

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.